Application no. and date | 18157435.1 (espacenet) (Federated) (European Patent Register), 20130604 | Patent/reg. no. and date | DK/EP 3348553, 20200708 | Publication date | 20180718 | Priority no. and date | US 201261656888 P, 20120607 | EP pub. no. and date |
EP 3348553 20180718 | Effective date | | Applicant/owner | Sloan-Kettering Institute for Cancer Research, 1275 York Avenue
New York, NY 10065, US, Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd. Suite 440 Los Angeles, CA 90024, US | Applicant ref. no. | P73479DK01 | Inventor | SMITH, Nicholas D., 1204 Beryl Street
San Diego, CA 92109, US, DILHAS, Anna, Häsingerstr. 32
4055 Basel, CH, OUERFELLI, Ouathek, 2077 Center Avenue, Apt. 3J
Fort Lee, NJ 07024, US, HERBERT, Mark R., 4180 Amoroso Street
San Diego, CA 92111, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | Title | KRYSTALLINSKE FORMER AF EN ANDROGEN RECEPTORMODULATOR | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|